直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

At the PTAB Blog

Federal Circuit PTAB Appeal Statistics Through May 31, 2022

June 28, 2022

Authored and Edited by Daniel F. Klodowski; Audrey J. Parker; Jason E. Stach; Elliot C. Cook

In May 2022, the Federal Circuit affirmed the PTAB on every issue in 7 (63.64%) cases, reversed or vacated the PTAB on every issue in 2 (18.18%) cases, issued a mixed outcome in 1 (9.09%) case, and dismissed 1 (9.09%) appeal.  A mixed outcome occurs when at least one issue is affirmed and at least one issue is vacated or reversed in an opinion, and a dismissal may occur, for example, when the Federal Circuit determines that it does not have jurisdiction to hear an appeal. 

Cumulatively through May 31, 2022, the Federal Circuit decided 1,041 appeals from the PTAB in IPRs, CBMs, and PGRs.  While the vast majority of these appeals came from IPRs, the number of PGR appeals has slowly increased over time, partially offsetting a near total decline in the number of CBM appeals.

In IPR appeals, the Federal Circuit has cumulatively affirmed the PTAB on every issue in 712 (72.73%) cases, and reversed or vacated the PTAB on every issue in 131 (13.38%) cases.  A mixed outcome on appeal occurred in 102 (10.42%) cumulative cases, and the court cumulatively dismissed 34 (3.47%) IPR appeals without rendering a decision on the merits.   

In CBM appeals, the Federal Circuit affirmed the PTAB on every issue in 37 (74%) cases, reversed or vacated the PTAB on every issue in 5 (10%) cases, issued a mixed outcome in 4 (8%) cases, and dismissed 4 (8%) cases.  These statistics are unchanged from our last report through April 30, 2022.

In PGR appeals, the Federal Circuit cumulatively affirmed the PTAB on every issue in 7 (58.33%) cases, issued a mixed outcome in 1 (8.33%) case, and reversed or vacated every issue in 4 (33.33%) cases.  No PGR appeals have been dismissed.

Taken together, in decisions for IPR, CBM, and PGR appeals, the Federal Circuit affirmed every issue in 756 (72.62%) cases, issued a mixed outcome in 107 (10.28%) cases, reversed or vacated every issue in 140 (13.45%) cases, and dismissed 38 (3.65%) cases.

An important tool helping the Federal Circuit manage its significant docket of PTAB appeals is the Rule 36 affirmance, through which the court affirms the PTAB without rendering a full written opinion.  Of the 1,041 IPR, CBM, and PGR appeals it has considered thus far, the Federal Circuit issued Rule 36 affirmances in 447 (42.94%) cases.  The court issued written opinions, including affirmances, reversals, dismissals, and mixed decisions, in 594 (57.06%) cases.  The ratio of Rule 36 affirmances to issued decisions has trended slightly downward over time and continued to decrease this month.

Stay tuned to the At the PTAB Blog for the latest updates, analysis, and statistics on all aspects of PTAB and Federal Circuit practice. Subscribe here to receive notifications of new posts via email.

Tags

Patent Trial and Appeal Board (PTAB), United States Court of Appeals for the Federal Circuit (CAFC)

Related Practices

Federal Circuit and Supreme Court Appeals

Patent Office Invalidation Proceedings

PTAB Invalidation Proceedings: IPR and PGR

Related Offices

Atlanta, GA

Reston, VA

Washington, DC

Contacts

Daniel F. Klodowski
Partner
Washington, DC
+1 202 408 4216
Email
Jason E. Stach
Partner
Atlanta, GA
+1 404 653 6428
Email
Elliot C. Cook
Partner
Reston, VA
+1 571 203 2738
Email

Related Insights

At the PTAB Blog

IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026

May 26, 2026

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Webinar

Changes at the PTAB from Settled Expectations to Real Parties in Interest to Director Involvement

May 18, 2026

Webinar

Federal Circuit IP Blog

Federal Circuit Affirms § 102(b) Invalidity; Source Code Commands Are Not Hearsay

May 14, 2026

Federal Circuit IP Blog

When “and” and “e.g.” Matter: Federal Circuit Revives VLSI vs. Intel Case

May 14, 2026

IP Updates

Tenth Circuit Sides with Netflix in Tiger King Copyright Challenge 

May 5, 2026

Conference

International Trade Commission Litigation & Enforcement

May 4-5, 2026

Washington, DC

Articles

Unpacking Squires’ Recent Discretionary Denial Guidance Focusing on American Manufacturing

April 24, 2026

Federal Circuit IP Blog

Federal Circuit Affirms District Court’s Invalidation of Patents Because Inventorship Could Not Be Corrected Without Giving All Inventors Notice and an Opportunity to Be Heard

April 22, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP